ARCHIVES

Congress Approves More Favorable Terms for Office-Administered Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 31 | August 8, 1997

Download PDF Visit The Full Archive

Related Articles

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990

DRCCA Board Votes To Pull NCI Out Of Joint Program With OSHA For Workplace Education And Prevention

January 29, 1982

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

October 17, 2008

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982

NIH director; Targets Increases Favor Established Researchers

May 9, 1997